Dynamic Light Scattering Spectroscopy as an Early Biomarker of Alzheimer’s Disease

Jeffrey Neill Weiss · 2025

Read Dynamic Light Scattering Spectroscopy as an Early Biomarker of Alzheimer’s Disease by Jeffrey Neill Weiss (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712130.txt.

Description

Jeffrey Neill Weiss presents a light-based eye test as an early marker of Alzheimer's disease in a 2025 proof-of-concept report. Finding the disease before symptoms show could let treatment start sooner and shorten drug trials. The retina is a piece of the brain that doctors can see directly, so Weiss aimed his method there.

The method tracks how tiny particles drift in retinal tissue by reading scattered light, in a five-second scan. Four patients with mild impairment and four healthy peers took the test, and all had normal standard eye exams. Each of the four patients went on to receive an Alzheimer's diagnosis about a year later. Their light readings differed from controls in a steady pattern. Weiss argues the test could become a non-invasive early screen.

Catalog record

CREATORJeffrey Neill Weiss
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11712130

Browse the full library · About the Tower of Babel